BRIEF-Rigel Pharmaceuticals expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017
October 07, 2016 at 07:36 AM EDT
* Expects to file an investigational new drug application (IND) with FDA for its first IRAK inhibitor in 2017 Source text for Eikon: Further company coverage:
